Skip to main content
56 results

Biologics are a class of medications that are specifically designed to target and modify specific components

Lung Volume Reduction (LVR) is a clinically proven and NICE approved therapy for reducing breathlessness in COPD. Changes in treatment means that minimally invasive options (e.g. valves) are now available, but the majority of eligible patients are not referred.

Originally presented at the PCRS Respiratory Conference 2020 Dr Glenis Scadding presents One airway: if they're wheezing, are they sneezing too?

Virtual consultations, virtual wards and virtual pulmonary rehab have enabled continued safe patient – practitioner interaction during the COVID-19 pandemic and looks set to remain in place due to clear benefits in terms of protecting vulnerable patients from unnecessary infection or travel, keep

Many of us have embraced digital learning over the past two years – attending online conferences, workshops and events. There is no doubt that digital learning is here to stay. But how do we maintain quality, how do we keep people engaged.

Digital health has come to the fore with the COVID pandemic. Some apps and digital strategies are welcome and we wish we had adopted them years ago – other initiatives are not so effective and we have concerns about how they will affect the healthcare we provide.

Vikki Knowles - Surrey: Minimising MDIs Independent Respiratory Nurse Specialist Vikki Knowles shares the early stages of work being done to minimise the use of Metered Dose Inhalers (MDIs) in their practice in Surrey and how that can positively impact the greener healthcare environment

Dr Kat Parker - Bristol: Switching to DPIs In this case study from Dr Kat Parker, she shares her experience of how her practice in Bristol has been switching patients from Metered Dose Inhalers (MDIs) to Dry Powder Inhalers (DPIs) where appropriate to do so, when and how they communicat